Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Saved in:
| Title: | Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis. |
|---|---|
| Authors: | de Moraes FCA; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil., de Souza Wagner PH; Department of Medicine, Federal University of Santa Catarina, Florianópolis, Brazil., Hirata RDC; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil., Burbano RMR; Human Cytogenetics Laboratory, Biological Science Institute, Federal University of Pará, Belém, Brazil., Hirata MH; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil. |
| Source: | Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2026 Jul; Vol. 26 (7), pp. 917-927. Date of Electronic Publication: 2026 Jan 21. |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1744-8328 |
|---|---|
| DOI: | 10.1080/14737140.2026.2617952 |
